Lv3
350 积分 2025-04-09 加入
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option
15天前
已完结
Adrenal insufficiency: identification and management—summary of new NICE guidance
15天前
已完结
Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center
15天前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
20天前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
24天前
已完结
Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta-Analysis and Systematic Review
26天前
已完结
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact
2个月前
已完结
Immune checkpoint inhibitor‐induced diabetes: Twists and turns of diabetology
3个月前
已完结
American Association of Clinical Endocrinology Disease State Clinical Review: Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Practical Case-Based Clinical Approach
4个月前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
4个月前
已完结
皖公网安备34019202002308
